Although, Krumbholz et al. (2008) reported similar BAFF serum protein concentrations in untreated MS patients and HC, they showed that treatment with (IFN)-β leads to strong upregulation of BAFF in blood leucocytes and serum [22]. Here, TNFSF13B is linked to myeloid sarcoma.